Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
00:00
Intro
This chapter examines obesity as a complex disease influenced by genetics, food accessibility, and demographics. It also discusses the economic implications of obesity and the advancements in weight reduction medicines that provide new hope for individuals facing weight management challenges.
Transcript
Play full episode
